Express Scripts Holding Company company logo

# 1st Gen Model Express Scripts Holding Company Drug stores & proprietary stores

66.13% successful of 62 deals
$59.51 Last close price
at 20-oct-2017

ESRX

Model's trade recommendations 2.25% Return for period

4.68% Annual return

$33.37B Market Cap

β 0.88  

ESRX

Model (following trade recommendations)

ESRX

Underlying stock

S&P 500

Index
Return for period 2.25%
-4.74%
1.78%
52wk return 10.44%
-14.51%
16.82%
52wk Range
56.81—77.14
2000.54—2399.63
Sortino ratio 0.75
Sharpe ratio 0.55
Norm. RMSE 0.50%
Downside risk 6.17%
Volatility 8.43%
  • BUY Analysts consensus recommendation

Express Scripts, Inc. is one of the largest pharmacy benefit management companies in North America. Through facilities in the states and Canada, the company serves thousands of client groups, including managed care organizations, insurance carriers, third-party administrators, employers and union-sponsored benefit plans.

Industry sector: Medical

Sector classification: Drug stores & proprietary stores

Deep Learning based analysis and prediction model for Express Scripts Holding Company (ESRX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 23, 2015.

Market data for ESRX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 574M
P/E 8.65
Shares Outstanding 578M
% Held by Insiders 0.68%
% Held by Institutions 88.69%
EPS (last reported FY) $6.39
EPS (last reported Q) $1.73
EPS, estimated (last reported Q) $1.71
Total revenues $100 B
Net income $3 B